表达 HER2 的癌症的临床试验
总计51796个结果
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research Group招聘中
-
University of MiamiNational Cancer Institute (NCI)尚未招聘
-
QuantumLeap Healthcare Collaborative招聘中乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤 | HER2阳性乳腺癌 | 血管肉瘤 | 局部晚期乳腺癌 | HER2 阴性乳腺癌 | TNBC - 三阴性乳腺癌 | 激素受体阳性肿瘤 | 激素受体阴性肿瘤 | 早期乳腺癌美国
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.招聘中
-
Olema Pharmaceuticals, Inc.主动,不招人
-
MedSIRStemline Therapeutics, Inc.尚未招聘晚期乳腺癌 | ER阳性乳腺癌 | HER2 阴性乳腺癌 | ESR1基因突变
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Assistance Publique - Hôpitaux de Paris未知乳腺癌 | 转移 | HR+/HER2 阴性乳腺癌
-
Olema Pharmaceuticals, Inc.Novartis招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteThe Shulas' Foundation招聘中
-
German Breast GroupGilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal Cancer... 和其他合作者主动,不招人
-
SOLTI Breast Cancer Research Group招聘中
-
Yongsheng WangJiangsu HengRui Medicine Co., Ltd.招聘中
-
Dana-Farber Cancer InstituteBreast Cancer Research Foundation; Array BioPharma完全的
-
Tianjin Medical University Cancer Institute and...招聘中
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.招聘中
-
Imperial College LondonMedical Research Council; ECMC招聘中
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey终止
-
Dana-Farber Cancer InstituteMacroGenics; Translational Breast Cancer Research Consortium主动,不招人
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead Sciences主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | HER2 阴性乳腺癌 | HR 阳性乳腺癌美国
-
European Organisation for Research and Treatment...Breast International Group; Menarini Group招聘中
-
Tanvex BioPharma USA, Inc.完全的乳腺癌 | 乳腺肿瘤 | HER2阳性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | 早期乳腺癌白俄罗斯, 智利, 乔治亚州, 匈牙利, 印度, 墨西哥, 秘鲁, 菲律宾, 俄罗斯联邦, 乌克兰
-
SynDevRx, Inc.招聘中
-
MacroGenicsZai Lab (Shanghai) Co., Ltd.主动,不招人胃癌 | 胃食管结合部癌 | HER2阳性胃癌大韩民国, 美国, 中国, 意大利, 台湾, 德国, 新加坡, 英国, 波兰
-
National Cancer Center, JapanH.U. Group Research Institute G.K.招聘中
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
International Cancer Research Group, United Arab...King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut für Quantenoptik... 和其他合作者招聘中激素受体阳性、HER2 阴性、晚期乳腺癌阿尔及利亚, 约旦, 沙特阿拉伯
-
Jennifer Lee Caswell-JinNational Cancer Institute (NCI); QED Therapeutics, Inc.终止
-
Jiangsu HengRui Medicine Co., Ltd.尚未招聘HER2 阳性复发性或转移性乳腺癌
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug Development Institute暂停HER2阳性乳腺癌 | ER 阴性乳腺癌 | PR-阴性乳腺癌 | 淋巴结阴性乳腺癌大韩民国, 法国, 以色列, 比利时, 瑞士, 澳大利亚
-
Fujian Medical University尚未招聘HER2阳性复发/转移性乳腺癌
-
Samsung Medical Center尚未招聘
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Bayer; United States Department of Defense; Canadian Cancer Trials...终止
-
Memorial Sloan Kettering Cancer Center招聘中乳腺癌 | HER2阳性乳腺癌 | 心脏毒性 | 乳腺癌第四期 | 乳腺癌一期 | 乳腺癌二期 | 乳腺癌三期 | HER2阳性转移性乳腺癌美国
-
University of WashingtonBreast Cancer Research Foundation尚未招聘解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性 HER2 阴性乳腺癌 | 转移性激素受体阳性乳腺癌 | 局部晚期不可切除 HER2 阴性乳腺癌 | 局部晚期不可切除的激素受体阳性乳腺癌美国